Cytokinetics, Incorporated
IT ˙ BIT ˙ US23282W6057
62,32 € 0,00 (0,00%)
2026-06-05
DEL PRIS
SecurityIT:1CYTK / Cytokinetics, Incorporated
InstitutionAmalgamated Bank
Latest Disclosed Ownership52,801 shares
Latest Disclosed Value $ 3,480
Amalgamated Bank reports 4.29% increase in ownership of 1CYTK / Cytokinetics, Incorporated

On May 8, 2026 - Amalgamated Bank filed a 13F-HR form disclosing ownership of 52,801 shares of Cytokinetics, Incorporated (IT:1CYTK) valued at $2,851,254 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 50,630 shares of Cytokinetics, Incorporated. This represents a change in shares of 4.29% during the quarter. The current value of the position is $3,290,558 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F CYTOKINETICS COM 23282W605 52,801 2,171 4.29 3 0.00 0.0266
2026-02-05 2025-12-31 13F CYTOKINETICS COM 23282W605 50,630 -1,783 -3.40 3 50.00 0.0232
2025-10-29 2025-09-30 13F CYTOKINETICS COM 23282W605 52,413 74 0.14 3 100.00 0.0206
2025-08-04 2025-06-30 13F CYTOKINETICS COM 23282W605 52,339 -226 -0.43 2 -50.00 0.0133
2025-04-25 2025-03-31 13F CYTOKINETICS COM 23282W605 52,565 -1,057 -1.97 2 0.00 0.0181
2025-02-04 2024-12-31 13F CYTOKINETICS COM 23282W605 53,622 0 0.00 3 0.00 0.0207
2024-10-30 2024-09-30 13F CYTOKINETICS COM 23282W605 53,622 -1,775 -3.20 3 -33.33 0.0233
2024-08-12 2024-06-30 13F CYTOKINETICS COM 23282W605 55,397 4,099 7.99 3 0.00 0.0256
2024-04-23 2024-03-31 13F CYTOKINETICS COM 23282W605 51,298 10,469 25.64 4 0.00 0.0308
2024-02-06 2023-12-31 13F CYTOKINETICS COM 23282W605 40,829 -1,024 -2.45 3 200.00 0.0272
2023-11-08 2023-09-30 13F CYTOKINETICS COM 23282W605 41,853 -509 -1.20 1 0.00 0.0105
2023-08-11 2023-06-30 13F CYTOKINETICS COM 23282W605 42,362 864 2.08 1 0.00 0.0112
2023-05-02 2023-03-31 13F CYTOKINETICS COM 23282W605 41,498 -2,446 -5.57 1 -50.00 0.0124
2023-02-10 2022-12-31 13F CYTOKINETICS COM 23282W605 43,944 83 0.19 2 -99.91 0.0180
2022-11-09 2022-09-30 13F CYTOKINETICS COM 23282W605 43,861 3,453 8.55 2,125 33.82 0.0205
2022-08-15 2022-06-30 13F CYTOKINETICS COM 23282W605 40,408 489 1.22 1,588 8.10 0.0148
2022-08-25 2022-03-31 13F/A-1 CYTOKINETICS COM 23282W605 39,919 -2,334 -5.52 1,469 -23.73 0.0114
2022-06-30 2022-03-31 13F CYTOKINETICS COM 23282W605 39,919 -2,334 1,469 0.0117
2022-02-15 2021-12-31 13F/A-1 CYTOKINETICS COM 23282W605 42,253 -147 -0.35 1,926 27.13 0.0142
2022-02-15 2021-12-31 13F CYTOKINETICS COM 23282W605 42,253 -147 1,926 0.0142
2021-10-29 2021-09-30 13F CYTOKINETICS COM 23282W605 42,400 4,628 12.25 1,515 102.54 0.0128
2021-08-16 2021-06-30 13F CYTOKINETICS COM 23282W605 37,772 28,175 293.58 748 235.43 0.0060
2021-05-13 2021-03-31 13F CYTOKINETICS COM 23282W605 9,597 -824 -7.91 223 2.76 0.0084
2021-02-12 2020-12-31 13F CYTOKINETICS COM 23282W605 10,421 290 2.86 217 -0.91 0.0082
2020-10-30 2020-09-30 13F CYTOKINETICS COM 23282W605 10,131 1,151 12.82 219 3.30 0.0095
2020-08-10 2020-06-30 13F CYTOKINETICS COM 23282W605 8,980 -1,369 -13.23 212 73.77 0.0098
2020-05-13 2020-03-31 13F CYTOKINETICS COM 23282W605 10,349 -415 -3.86 122 7.02 0.0030
2020-02-13 2019-12-31 13F CYTOKINETICS COM 23282W605 10,764 622 6.13 114 -0.87 0.0021
2019-11-13 2019-09-30 13F CYTOKINETICS COM 23282W605 10,142 -117 -1.14 115 0.00 0.0024
2019-08-14 2019-06-30 13F CYTOKINETICS COM 23282W605 10,259 10,259 115 0.0027
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.